Publications in collaboration with researchers from Clínica Universitaria de Navarra (20)

2025

  1. Association of [68Ga]Ga-PSMA-11 PET/CT Metrics with PSA Persistence Following Radical Prostatectomy in Patients with Intermediate- and High-Risk Prostate Cancer

    Diagnostics, Vol. 15, Núm. 3

  2. Comparison of staging using [68Ga]Ga-PSMA-11 PET/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 44, Núm. 2

  3. State of the art and future perspectives of new radionuclides in Nuclear Medicine. Part I

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 44, Núm. 1

  4. State of the art and future perspectives of new radionuclides in Nuclear Medicine. Part II

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 44, Núm. 3

  5. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut, Vol. 74, Núm. 2, pp. 270-283

  6. The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism

    European Radiology

2021

  1. In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles

    Journal of Drug Delivery Science and Technology, Vol. 64

2020

  1. Incidental diagnosis of neuroendocrine tumour with 68Ga-PSMA PET/CT: Report of clinical case

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 2, pp. 102-103

2015

  1. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 97, pp. 280-289

  2. Zein nanoparticles for oral folic acid delivery

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 450-457

2011

  1. Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles

    Molecular Imaging and Biology, Vol. 13, Núm. 6, pp. 1215-1223

2010

  1. Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment

    Molecular Imaging and Biology, Vol. 12, Núm. 2, pp. 210-217

2009

  1. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles

    European Journal of Pharmaceutical Sciences, Vol. 37, Núm. 3-4, pp. 231-240

  2. Evaluation of CdZnTe as neutron detector around medical accelerators

    Radiation Protection Dosimetry, Vol. 133, Núm. 4, pp. 193-199

  3. PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector

    Gene Therapy, Vol. 16, Núm. 1, pp. 136-141

  4. Synthesis of S-[13N]nitrosoglutathione (13N-GSNO) as a new potential PET imaging agent

    Applied Radiation and Isotopes, Vol. 67, Núm. 1, pp. 95-99

2008

  1. Utilización de la11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 2, pp. 103-111

2007

  1. Monte Carlo neutron doses estimations inside a PET cyclotron vault room

    Radiation Protection Dosimetry, Vol. 126, Núm. 1-4, pp. 477-481

  2. Neutron spectrometry in a PET cyclotron with a Bonner sphere system

    Radiation Protection Dosimetry, Vol. 126, Núm. 1-4, pp. 371-375

2005

  1. Síntesis de Radiofármacos PET

    Tomografía Molecular de pequeños animales: Fundamentos (Navarra Gráfica), pp. 19-34